Original Article
Anatomic and clinical implications of venous drainage variations in superior segment resections for clinical T1N0 non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(12)
:3256-3266
.
(31 December 2024)
A novel bioassay reflecting response to immune checkpoint inhibitor therapy in non-small cell lung cancer with malignant pleural effusion
Translational Lung Cancer Research
2024;
13
(12)
:3267-3277
.
(31 December 2024)
Successful long-term outcome of neoadjuvant sequential targeted therapy and chemotherapy for stage III non-small cell lung carcinoma: 10 case series
Translational Lung Cancer Research
2024;
13
(12)
:3278-3288
.
(31 December 2024)
Health-related quality of life analysis from ENTER, a randomized, controlled phase III trial of whole-brain radiotherapy with and without concurrent erlotinib in NSCLC with brain metastases
Translational Lung Cancer Research
2024;
13
(12)
:3289-3302
.
(31 December 2024)
Radiomicsmetabolic signature profiles for advanced non-small cell lung cancer with chemoimmunotherapy by reflecting biological function and survival
Translational Lung Cancer Research
2024;
13
(12)
:3303-3322
.
(31 December 2024)
Quantitative peripheral live single T-cell dynamic polyfunctionality profiling predicts lung cancer checkpoint immunotherapy treatment response and clinical outcomes
Translational Lung Cancer Research
2024;
13
(12)
:3323-3343
.
(31 December 2024)
Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective study
Translational Lung Cancer Research
2024;
13
(12)
:3344-3351
.
(31 December 2024)
Development and validation of a nomogram for predicting visceral pleural invasion in patients with early-stage non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(12)
:3352-3363
.
(31 December 2024)
A non-interventional biomarker study in patients with adenocarcinoma of the lung treated with nintedanib plus docetaxel following progression on chemotherapy and/or immunotherapy: LUME-BioNIS
Translational Lung Cancer Research
2024;
13
(12)
:3364-3381
.
(31 December 2024)
Efficacy, safety, and quality of life of dabrafenib plus trametinib treatment in Chinese patients with BRAFV600E mutation-positive metastatic non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(12)
:3382-3391
.
(31 December 2024)
A prognostic nomogram of non-small cell lung cancer based on tumor marker inflammatory nutrition score
Translational Lung Cancer Research
2024;
13
(12)
:3392-3406
.
(31 December 2024)
Construction of a neutrophil extracellular trap formation-related gene model for predicting the survival of lung adenocarcinoma patients and their response to immunotherapy
Translational Lung Cancer Research
2024;
13
(12)
:3407-3425
.
(31 December 2024)
Inhibition of miR-9-3p facilitates ferroptosis by activating SAT1/p53 pathway in lung adenocarcinoma
Translational Lung Cancer Research
2024;
13
(12)
:3426-3442
.
(31 December 2024)
Prediction of early lung adenocarcinoma spread through air spaces by machine learning radiomics: a cross-center cohort study
Translational Lung Cancer Research
2024;
13
(12)
:3443-3459
.
(31 December 2024)
A retrospective study of the efficacy and safety of immune checkpoint inhibitors combined with chemotherapy for the treatment of SMARCA4-deficient thoracic tumors
Translational Lung Cancer Research
2024;
13
(12)
:3460-3472
.
(31 December 2024)
Effectiveness of artificial intelligence for detecting operable lung cancer on chest radiographs
Translational Lung Cancer Research
2024;
13
(12)
:3473-3485
.
(31 December 2024)
Performance of deep learning model and radiomics model for preoperative prediction of spread through air spaces in the surgically resected lung adenocarcinoma: a two-center comparative study
Translational Lung Cancer Research
2024;
13
(12)
:3486-3499
.
(31 December 2024)
EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAFV600E mutation: a multi-center real-world experience in China
Translational Lung Cancer Research
2024;
13
(12)
:3500-3512
.
(31 December 2024)
Long-term high fat diet aggravates the risk of lung fibrosis and lung cancer: transcriptomic analysis in the lung tissues of obese mice
Translational Lung Cancer Research
2024;
13
(12)
:3513-3525
.
(31 December 2024)
Validation of T stage classification strategy for >2 cm ground-glass opacity non-small cell lung cancer: a retrospective cohort study
Translational Lung Cancer Research
2024;
13
(12)
:3526-3537
.
(31 December 2024)
Characteristics of the immune microenvironment and their clinical significance in lung adenocarcinoma patients with different ALK fusion variants
Translational Lung Cancer Research
2024;
13
(12)
:3538-3554
.
(31 December 2024)
Spontaneous ventilation video-assisted thoracoscopic surgery for octogenarian non-small cell lung cancer patients: a non-inferiority study
Translational Lung Cancer Research
2024;
13
(12)
:3555-3565
.
(31 December 2024)
Enhancing the prediction of KRAS mutation status in Asian lung adenocarcinoma: a comprehensive approach combining clinical, dual-energy spectral computed tomography, and radiomics features
Translational Lung Cancer Research
2024;
13
(12)
:3566-3578
.
(31 December 2024)
Machine learning-based radiomics for guiding lymph node dissection in clinical stage I lung adenocarcinoma: a multicenter retrospective study
Translational Lung Cancer Research
2024;
13
(12)
:3579-3589
.
(31 December 2024)
Discrepancies in PD-L1 expression, lymphocyte infiltration, and tumor mutational burden in non-small cell lung cancer and matched brain metastases
Translational Lung Cancer Research
2024;
13
(12)
:3590-3602
.
(31 December 2024)
Radiotherapy for oligoprogressive disease in non-small cell lung cancer treated with pembrolizumab in first-line setting: a retrospective study
Translational Lung Cancer Research
2024;
13
(12)
:3603-3615
.
(31 December 2024)
Quantitative evaluation of accumulated and planned dose deviations in patients undergoing gated and non-gated lung stereotactic body radiation therapy patients: a retrospective analysis
Translational Lung Cancer Research
2024;
13
(12)
:3616-3628
.
(31 December 2024)
Prognostic value of ground-glass opacity on computed tomography for patients with pathological stage IA3 lung adenocarcinoma: a multicenter retrospective cohort study
Translational Lung Cancer Research
2024;
13
(12)
:3629-3641
.
(31 December 2024)
Development of an AI model for predicting hypoxia status and prognosis in non-small cell lung cancer using multi-modal data
Translational Lung Cancer Research
2024;
13
(12)
:3642-3656
.
(31 December 2024)
Identification and validation of pyroptosis patterns with a novel quantification system for the prediction of prognosis in lung squamous cell carcinoma
Translational Lung Cancer Research
2024;
13
(12)
:3657-3674
.
(31 December 2024)
Efficacy and safety of consolidative thoracic radiotherapy after first-line chemoimmunotherapy in patients with extensive-stage small-cell lung cancer: a retrospective cohort study
Translational Lung Cancer Research
2024;
13
(12)
:3675-3691
.
(31 December 2024)
Review Article
Fuel for thought: targeting metabolism in lung cancer
Translational Lung Cancer Research
2024;
13
(12)
:3692-3717
.
(31 December 2024)
Emerging insights into STK11, KEAP1 and KRAS mutations: implications for immunotherapy in patients with advanced non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(12)
:3718-3730
.
(31 December 2024)
Impact of lymph node involvement in pulmonary carcinoids: a narrative review
Translational Lung Cancer Research
2024;
13
(12)
:3731-3740
.
(31 December 2024)
Lung cancer organoid-based drug evaluation models and new drug development application trends
Translational Lung Cancer Research
2024;
13
(12)
:3741-3763
.
(31 December 2024)
Mapping the evolution and frontiers of Translational Lung Cancer Research: a bibliometric analysis and literature review
Translational Lung Cancer Research
2024;
13
(12)
:3764-3777
.
(31 December 2024)
The current landscape and prospects of antibody-drug conjugates for lung cancer brain metastases: a narrative review
Translational Lung Cancer Research
2024;
13
(12)
:3778-3794
.
(31 December 2024)
Case Report: iMDT Corner
Long-term survival after combination therapy with atezolizumab in a patient with small-cell lung cancer: a case report
Translational Lung Cancer Research
2024;
13
(12)
:3795-3806
.
(31 December 2024)
Case Report
A rationale for the poor response to alectinib in a patient with adenocarcinoma of the lung harbouring a STRN-ALK fusion by artificial intelligence and molecular modelling: a case report
Translational Lung Cancer Research
2024;
13
(12)
:3807-3814
.
(31 December 2024)
Editorial Commentary
Targeting a cure in anaplastic lymphoma kinase-positive non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(12)
:3815-3818
.
(31 December 2024)
Patient-focused insights: how emotional distress shapes immunotherapy response in non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(12)
:3819-3823
.
(31 December 2024)
A potential central nervous system niche for trastuzumab deruxtecan in patients with HER2-expressing non-small cell lung cancer
Translational Lung Cancer Research
2024;
13
(12)
:3824-3830
.
(31 December 2024)
Can circulating tumor DNA guide treatment de-escalation in metastatic lung adenocarcinoma harboring actionable genomic alterations?
Translational Lung Cancer Research
2024;
13
(12)
:3831-3834
.
(31 December 2024)
Finding the right HARMONi-A
Translational Lung Cancer Research
2024;
13
(12)
:3835-3837
.
(31 December 2024)
